Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2016, Article ID 7354018, 6 pages
http://dx.doi.org/10.1155/2016/7354018
Clinical Study

Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever

1Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
2Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo, Egypt
3Department of Rheumatology, Faculty of Medicine, Cairo University, Cairo, Egypt

Received 2 August 2016; Revised 19 November 2016; Accepted 22 November 2016

Academic Editor: Bruce M. Rothschild

Copyright © 2016 Hala M. Lofty et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ben-Chetrit and I. Touitou, “Familial mediterranean fever in the world,” Arthritis Care and Research, vol. 61, no. 10, pp. 1447–1453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Fonnesu, C. Cerquaglia, M. Giovinale et al., “Familial mediterranean fever: a review for clinical management,” Joint Bone Spine, vol. 76, no. 3, pp. 227–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. French FMF Consortium, “A candidate gene for familial Mediterranean fever,” Nature Genetics, vol. 17, no. 1, pp. 25–31, 1997. View at Google Scholar
  4. M. Lidar and A. Livneh, “Familial mediterranean fever: clinical, molecular and management advancements,” Netherlands Journal of Medicine, vol. 65, no. 9, pp. 318–324, 2007. View at Google Scholar · View at Scopus
  5. A. Livneh, P. Langevitz, D. Zemer et al., “Criteria for the diagnosis of familial Mediterranean fever,” Arthritis and Rheumatism, vol. 40, no. 10, pp. 1879–1885, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Berkun and E. M. Eisenstein, “Diagnostic criteria of familial Mediterranean fever,” Autoimmunity Reviews, vol. 13, no. 4-5, pp. 388–390, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H. J. Lachmann, B. Şengül, T. U. Yavuzşen et al., “Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations,” Rheumatology, vol. 45, no. 6, pp. 746–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Tunca, G. Kirkali, M. de Soytürk, S. Akar, M. B. Pepys, and P. N. Hawkins, “Acute phase response and evolution of familial Mediterranean fever,” The Lancet, vol. 353, no. 9162, p. 1415, 1999. View at Google Scholar · View at Scopus
  9. C. Korkmaz, H. Özdogan, O. Kasapçopur, and H. Yazici, “Acute phase response in familial mediterranean fever,” Annals of the Rheumatic Diseases, vol. 61, no. 1, pp. 79–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Bilginer, T. Akpolat, and S. Ozen, “Renal amyloidosis in children,” Pediatric Nephrology, vol. 26, no. 8, pp. 1215–1227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Merlini and V. Bellotti, “Molecular mechanisms of amyloidosis,” New England Journal of Medicine, vol. 349, no. 6, pp. 583–596, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Berkun, S. Padeh, B. Reichman et al., “A single testing of serum amyloid A level as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever,” Seminars in Arthritis and Rheumatism, vol. 37, no. 3, pp. 182–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Kallinich, D. Haffner, T. Niehues et al., “Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement,” Pediatrics, vol. 119, no. 2, pp. e474–e483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Özen, Y. Bilginer, N. A. Ayaz, and M. Calguneri, “Anti-interleukin 1 treatment for patients with familial mediterranean fever resistant to colchicine,” Journal of Rheumatology, vol. 38, no. 3, pp. 516–518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Duzova, A. Bakkaloglu, N. Besbas et al., “Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever,” Clinical and Experimental Rheumatology, vol. 21, no. 4, pp. 509–514, 2003. View at Google Scholar · View at Scopus
  16. E. Ben-Chetrit and S. Aamar, “About colchicine compliance, resistance and virulence,” Clinical and Experimental Rheumatology, vol. 27, supplement 53, no. 2, pp. S1–S3, 2009. View at Google Scholar
  17. F. Yalçinkaya, S. Özen, Z. B. Özçakar et al., “A new set of criteria for the diagnosis of familial mediterranean fever in childhood,” Rheumatology, vol. 48, no. 4, pp. 395–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. R. Kind and M. B. Pepys, “The role of C-reactive protein (CRP) measurement in clinical practice,” Journal of Internal Medicine, vol. 5, pp. 112–151, 1984. View at Google Scholar
  19. A. Biopong and J. Burthem, “Supplementary techniques including blood parasite,” in Practical Hematology, B. J. Bain, I. Bates, M. A. Laffan, and S. M. Lewis, Eds., vol. 6, p. 102, Elseiver, 2012. View at Google Scholar
  20. T. Nakayama, S. Sonoda, T. Urano, T. Yamada, and M. Okada, “Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases,” Clinical Chemistry, vol. 39, no. 2, pp. 293–297, 1993. View at Google Scholar · View at Scopus
  21. W. T. Klimecki, B. W. Futscher, T. M. Grogan, and W. S. Dalton, “P-glycoprotein expression and function in circulating blood cells from normal volunteers,” Blood, vol. 83, no. 9, pp. 2451–2458, 1994. View at Google Scholar · View at Scopus